This inventor holds 2 USPTO granted patents and 4 EPO patents. Top assignee: Ucl Business Plc. Active years: 2019-2020.
Location History:
- Greater London, GB (2019)
- London, GB (2020)
Company Filing History:
Years Active: 2019-2020
Title: Alex Peter Dyson: Innovator in Pharmaceutical Chemistry
Introduction
Alex Peter Dyson is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Dyson's work focuses on compounds that have therapeutic applications.
Latest Patents
Dyson's latest patents include the invention of crystalline diethylamine tetrathiomolybdate and its pharmaceutical uses. This invention relates to a crystalline diethylamine tetrathiomolybdate salt (DEA-TTM) and outlines methods for producing this crystalline salt. The patent also details pharmaceutical compositions that incorporate the crystalline DEA-TTM salt. Furthermore, it discusses the use of this compound in treating conditions that require reduced metabolism of an organ or the entire body, particularly in patients needing therapeutic intervention.
Career Highlights
Throughout his career, Dyson has worked with various companies, including UCL Business Plc and Magnus Oxygen Limited. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Dyson has collaborated with notable individuals in his field, including Daniel Gooding and Joanne Holland. These partnerships have likely enhanced his research and development efforts.
Conclusion
Alex Peter Dyson is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact medical treatments significantly. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.